Graybug Vision Inc. (GRAY) IPO Opens 19% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall St climbs after US, Iran pause conflict; focus on Fed, earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices near one-week low after US, Iran pause fighting over weekend
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
Graybug Vision Announces Pricing of Upsized Initial Public Offering
September 24, 2020 8:14 PM EDTREDWOOD CITY, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the pricing of its upsized initial public offering of 5,625,000 shares of common stock at a public offering price of $16.00Â per share. All of the shares are being offered by Graybug. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Graybug, are expected to be $90.0 million. In addition, Graybug has... More
